Richard Scott Struthers insider trades
Open-market stock purchases and sales by Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 8, 2019.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +156%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 16, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold | $490K |
| Mar 16, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold | $332K |
| Feb 23, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 23, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 18, 2025 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 18, 2025 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- CRNX Crinetics Pharmaceuticals, Inc: 2 buys, 21 sales, last May 29, 2026
Get free alerts when Richard Scott Struthers files a new trade →